📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Base Genomics

1.1 - Company Overview

Base Genomics Logo

Base Genomics

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of epigenetics technologies focused on developing a blood test for early-stage cancer and minimal residual disease, based on TAPS (TET-assisted pyridine borane sequencing), a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford, using a novel chemical reaction that converts methylated cytosine to thymine under mild conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Base Genomics

e-Zyvec Logo

e-Zyvec

HQ: France Website
  • Description: Provider of molecular biology solutions for academic and industrial scientists conducting research with genetic engineering applications; a biotechnology company specializing in genetic engineering, founded in 2016 and headquartered in Loos, France.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full e-Zyvec company profile →
BioLamina Logo

BioLamina

HQ: Sweden Website
  • Description: Provider of cell culture matrices based on human recombinant laminins for primary cells and stem cell applications. Products include Biolaminin 521 LN and 521 MX for chemically defined, feeder-free self-renewal of human ES/iPS cells (LN: animal origin-free; MX: animal origin-free to the secondary level); 521 CTG for clinical studies and feeder-free culture of PSCs, MSCs, and progenitor cells; 111/121 LN as general attachment proteins; and 211 LN for tissue-specific cell growth and differentiation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioLamina company profile →
Frugi Bio Logo

Frugi Bio

HQ: United States Website
  • Description: Provider of modular, paper-based, secure diagnostics for viral outbreak management using synthetic biology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Frugi Bio company profile →
Diagnoplex Logo

Diagnoplex

HQ: Switzerland Website
  • Description: Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diagnoplex company profile →
Bode Technology Logo

Bode Technology

HQ: United States Website
  • Description: Provider of forensic DNA analysis products and services for government agencies, serving the law enforcement and identification markets. Offers state-of-the-art human DNA analysis and innovative DNA collection products, with services including high-throughput DNA testing, casework analysis, and missing person identification.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bode Technology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Base Genomics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Base Genomics

2.2 - Growth funds investing in similar companies to Base Genomics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Base Genomics

4.2 - Public trading comparable groups for Base Genomics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Base Genomics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Base Genomics

What does Base Genomics do?

Base Genomics is a provider of epigenetics technologies focused on developing a blood test for early-stage cancer and minimal residual disease, based on TAPS (TET-assisted pyridine borane sequencing), a new invention to sequence DNA methylation developed at the Ludwig Institute for Cancer Research Branch at the University of Oxford, using a novel chemical reaction that converts methylated cytosine to thymine under mild conditions.

Who are Base Genomics's competitors?

Base Genomics's competitors and similar companies include e-Zyvec, BioLamina, Frugi Bio, Diagnoplex, and Bode Technology.

Where is Base Genomics headquartered?

Base Genomics is headquartered in United Kingdom.

How many employees does Base Genomics have?

Base Genomics has 1,000 employees 🔒.

When was Base Genomics founded?

Base Genomics was founded in 2010 🔒.

What sector and industry vertical is Base Genomics in?

Base Genomics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Base Genomics

Who are the top strategic acquirers in Base Genomics's sector and industry

Top strategic M&A buyers and acquirers in Base Genomics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Base Genomics?

Top strategic M&A buyers groups and sectors for Base Genomics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Base Genomics's sector and industry vertical

Which are the top PE firms investing in Base Genomics's sector and industry vertical?

Top PE firms investing in Base Genomics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Base Genomics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Base Genomics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Base Genomics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Base Genomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Base Genomics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Base Genomics?

The key public trading comparables and valuation benchmarks for Base Genomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Base Genomics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Base Genomics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Base Genomics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Base Genomics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Base Genomics's' sector and industry vertical?

Access recent funding rounds and capital raises in Base Genomics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Base Genomics

Launch login modal Launch register modal